Literature DB >> 12506482

[Three cases of advanced and recurrent gastric cancer treated with paclitaxel after TS-1 administration].

Yoshiyuki Fujiwara1, Shigeyuki Tamura, Setsuko Yoshioka, Yoshihiro Okada, Shuji Takiguchi, Masahiko Yano, Takushi Yasuda, Morito Monden.   

Abstract

The importance of chemotherapy in the treatment of gastric cancer has increased after the appearance of more effective new agents such as TS-1. Therefore, the development of second line chemotherapy following TS-1 administration is needed urgently. Recently, we treated three cases of advanced and recurrent gastric cancers, using paclitaxel after TS-1 treatment. We herein describe these cases and discuss the therapeutic effect of paclitaxel and drug-related side effects in these patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12506482

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  1 in total

1.  Doxifluridine combined with weekly paclitaxel for second-line treatment in patients with gastric cancer resistant to TS-1.

Authors:  Wataru Arai; Yoshinori Hosoya; Masanobu Hyodo; Hidenori Haruta; Kentaro Kurashina; Shin Saito; Yuuki Hirashima; Taku Yokoyama; Toru Zuiki; Kazuya Sakuma; Yoshikazu Yasuda; Hideo Nagai
Journal:  Int J Clin Oncol       Date:  2007-04-27       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.